Changwen Sun – Trademark Portfolio
Entity Type: 01
Changwen Sun owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as JZVMY, XWMVL, and NRZPYU. Of these, 3 are registered and 4 are pending. The portfolio spans 6 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 25 (Clothing). Headquartered in Yunnan Province.
No. 20, Group 2, Muren Street, Muren Village Committee, Wumiao Town, Funing County, Wenshan Autonomous Prefecture
Yunnan Province 663400 , CN
Showing of trademarks Trademarks
Trademark Classifications
Changwen Sun's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Changwen Sun have?
Changwen Sun has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending.
What trademark classes does Changwen Sun file in?
Changwen Sun files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Changwen Sun's most well-known trademarks?
Changwen Sun's registered trademark portfolio includes well-known marks such as JZVMY, XWMVL, and NRZPYU. These are among 3 currently registered trademarks in the portfolio.
What is Changwen Sun's trademark registration success rate?
Changwen Sun has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.